Abstract |
Philadelphia chromosome positive chronic myeloid leukemia has a progressive course starting in a benign phase and terminating in a blastic phase. In this study, we show that human homolog double minute 2 (HDM2) inhibition, with MI-219-a novel compound, and consequently p53 stabilization induce chronic myeloid leukemia (CML) blast crisis cells to undergo apoptosis regardless of the presence of the T315I mutation in the BCR-ABL kinase domain. The response to MI-219 is associated with the downregulation of c-Myc and the induction of p21(WAF1). The p53 target and pro-apoptotic proteins PUMA, Noxa and Bax are induced, whereas full length Bid protein decreases with increased activity of pro-apoptotic cleaved Bid, and decrease of Mcl-1 is observed by increased caspase activity. CD95/FAS ( FAS antigen) receptor is also induced by MI-219, indicating that both intrinsic and extrinsic apoptotic responses are transcriptionally induced. In addition, p53 protein accumulates in the mitochondrial fraction of treated cells involved in transcription-independent induction of apoptosis. We conclude that HDM-2 inhibition with MI-219 effectively induces p53-dependent apoptosis in most blast crisis CML cells, with or without BCR-ABL mutation(s).
|
Authors | L F Peterson, E Mitrikeska, D Giannola, Y Lui, H Sun, D Bixby, S N Malek, N J Donato, S Wang, M Talpaz |
Journal | Leukemia
(Leukemia)
Vol. 25
Issue 5
Pg. 761-9
(May 2011)
ISSN: 1476-5551 [Electronic] England |
PMID | 21350558
(Publication Type: Journal Article)
|
Chemical References |
- Apoptosis Regulatory Proteins
- BAX protein, human
- BBC3 protein, human
- Indoles
- MI-291
- PMAIP1 protein, human
- Proto-Oncogene Proteins
- Proto-Oncogene Proteins c-bcl-2
- Spiro Compounds
- TP53 protein, human
- Tumor Suppressor Protein p53
- bcl-2-Associated X Protein
- MDM2 protein, human
- Proto-Oncogene Proteins c-mdm2
|
Topics |
- Adult
- Aged
- Apoptosis
- Apoptosis Regulatory Proteins
(metabolism)
- Blast Crisis
(drug therapy, metabolism, pathology)
- Blotting, Western
- Female
- Flow Cytometry
- Genes, abl
- Humans
- Indoles
(pharmacology)
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
(drug therapy, metabolism, pathology)
- Male
- Middle Aged
- Mutation
(genetics)
- Proto-Oncogene Proteins
(metabolism)
- Proto-Oncogene Proteins c-bcl-2
(metabolism)
- Proto-Oncogene Proteins c-mdm2
(antagonists & inhibitors, metabolism)
- Spiro Compounds
(pharmacology)
- Tumor Cells, Cultured
- Tumor Suppressor Protein p53
(chemistry, genetics, metabolism)
- bcl-2-Associated X Protein
(metabolism)
|